Palbociclib Hydrochloride (20:37)-impurities | Pharmaffiliates

Palbociclib Hydrochloride (20:37)

Palbociclib Hydrochloride (20:37), sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer. Reference standards of Palbociclib Hydrochloride (20:37) API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Palbociclib Hydrochloride (20:37) - API Standards
    [catalogue_number] => PA 16 4130000
    [category_ids] => ,75,76,78,70,82,
    [chemical_name] => 
    [weight] => 20(447.54) + 37(36.46)
    [form] => 20(C24H29N7O2) . 37(HCl)
    [cas] => 571189-11-2
    [pslug] => 571189-11-2-palbociclib-hydrochloride-20-37-api-standards-pa164130000
    [latest_product] => 0
    [linkproducts] => 1
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 16 4130000

Palbociclib Hydrochloride (20:37) - API Standards


  • Catalogue No.:PA 16 4130000

  • CAS :

    571189-11-2

  • Molecular Formula : 20(C24H29N7O2) . 37(HCl)

  • Molecular Weight : 20(447.54) + 37(36.46)